Related Experiment Video
Updated: Jan 5, 2026
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Natural killer cells control metastasis via structural editing of primary tumors in mice
Batya Isaacson1, Ofer Mandelboim2
1The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, The Hebrew University Medical School, IMRIC, POB 12272, 91120, Jerusalem, Israel.
Abstract:
Natural killer (NK) cells are innate immune lymphocytes which express an array of activating and inhibitory receptors. These receptors bind a large spectrum of ligands, which are expressed on stressed, malignantly transformed or virally infected cells, as well as on bacterial, fungal, and parasitic pathogens. The decision on whether or not to kill the target is based on the integration of activating and inhibitory signals sent downstream from NK cell receptors. One of the most prominent NK cell activating receptor families is the family of natural cytotoxicity receptors (NCRs) which includes NKp30, NKp44, and NKp46. NKp46 is the only NCR to have a fully functional mouse orthologue denoted Ncr1. Despite a large body of evidence highlighting its importance in the clearance of both solid and liquid tumors, the membrane-bound tumor ligand for NKp46 and its mouse orthologue Ncr1 is still unknown. Here we review the discovery of a novel role for NKp46/Ncr1, not only in tumor clearance but also in prevention of metastasis by structural editing of primary tumors.
Insights
Natural killer cell receptor NKp46 and its mouse counterpart Ncr1 are crucial for clearing tumors. This review highlights their newly discovered role in preventing metastasis by altering primary tumor structure.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Natural killer (NK) cells are key players in innate immunity, utilizing activating and inhibitory receptors to target abnormal cells and pathogens.
- The natural cytotoxicity receptors (NCRs), including NKp46, are prominent activating receptors on NK cells.
- While NKp46 is vital for tumor clearance, its specific tumor ligand remains unidentified.
Purpose of the Study:
- To review the discovery of a novel function for NKp46/Ncr1.
- To explore the role of NKp46/Ncr1 in preventing cancer metastasis.
- To investigate the mechanism of NKp46/Ncr1 in structural editing of primary tumors.
Main Methods:
- Literature review of studies on NK cells, NCRs, and NKp46/Ncr1.
- Analysis of existing data on NK cell-mediated tumor surveillance and metastasis.
- Synthesis of findings regarding the interaction between NKp46/Ncr1 and tumor microenvironments.
Main Results:
- NKp46/Ncr1 plays a significant role in the clearance of both solid and liquid tumors.
- A novel function of NKp46/Ncr1 in preventing metastasis has been identified.
- NKp46/Ncr1 contributes to metastasis prevention through structural editing of primary tumors.
Conclusions:
- NKp46/Ncr1 is essential for anti-tumor immunity, extending beyond direct tumor cell killing.
- The receptor's role in modifying primary tumor structure represents a new paradigm in cancer immunosurveillance.
- Further research into NKp46/Ncr1 ligands and mechanisms could yield novel therapeutic strategies against cancer metastasis.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...